- Home
- NMT vs MIST Comparison
NMT vs MIST Comparison
Compare NMT & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMT | MIST |
|---|---|---|
| Founded | 1993 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.2M | 146.9M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NMT | MIST |
|---|---|---|
| Price | $11.53 | $0.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 16.9K | ★ 1.7M |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.11 | $1.00 |
| 52 Week High | $13.70 | $3.06 |
Technical Indicators
Market Signals| Indicator | NMT | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 23.50 | 40.59 |
| Support Level | $11.39 | $1.01 |
| Resistance Level | $11.86 | $1.42 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 3.28 | 16.67 |
Price Performance
Historical ComparisonAbout NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.